Cargando…
Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus
BACKGROUND: The effects of switching from prandial premixed insulin therapy (PPT) injected three times a day to basal plus two times bolus insulin therapy (B2B) on glycemic control and quality of life were investigated in patients with type 2 diabetes mellitus. METHODS: The clinical course was prosp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003145/ https://www.ncbi.nlm.nih.gov/pubmed/24790413 http://dx.doi.org/10.2147/DDDT.S62709 |
_version_ | 1782313822935056384 |
---|---|
author | Ito, Hiroyuki Abe, Mariko Antoku, Shinichi Omoto, Takashi Shinozaki, Masahiro Nishio, Shinya Mifune, Mizuo Togane, Michiko |
author_facet | Ito, Hiroyuki Abe, Mariko Antoku, Shinichi Omoto, Takashi Shinozaki, Masahiro Nishio, Shinya Mifune, Mizuo Togane, Michiko |
author_sort | Ito, Hiroyuki |
collection | PubMed |
description | BACKGROUND: The effects of switching from prandial premixed insulin therapy (PPT) injected three times a day to basal plus two times bolus insulin therapy (B2B) on glycemic control and quality of life were investigated in patients with type 2 diabetes mellitus. METHODS: The clinical course was prospectively observed during the first 16 weeks after switching to B2B (insulin glargine plus insulin glulisine before breakfast and dinner) in 27 subjects previously treated with PPT using 50/50 premixed insulin. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) was administered at the start and end of the study. RESULTS: The glycated hemoglobin (HbA(1c)) level (8.3%±1.8% to 8.2%±1.1%) and the DTSQ score did not change between the start and end of the study. An improvement in HbA(1c) level was found in nine (33%) subjects. The change in HbA(1c) showed a significant negative correlation with baseline HbA(1c), and was significantly better in patients with a baseline HbA(1c) >8.0% than in those with an HbA(1c) ≤8.0% (−0.9±2.0 versus 0.3±0.6, respectively, P=0.02). The change in DTSQ score representing treatment satisfaction was significantly greater in patients whose HbA(1c) level was improved than in those in whom it was not (2.7±3.6 versus −0.8±3.5, P=0.04). CONCLUSION: B2B was noninferior to PPT with regard to HbA(1c) levels in patients with type 2 diabetes mellitus. B2B should be considered particularly for subjects whose glycemic control is poor despite PPT. |
format | Online Article Text |
id | pubmed-4003145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-40031452014-04-30 Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus Ito, Hiroyuki Abe, Mariko Antoku, Shinichi Omoto, Takashi Shinozaki, Masahiro Nishio, Shinya Mifune, Mizuo Togane, Michiko Drug Des Devel Ther Original Research BACKGROUND: The effects of switching from prandial premixed insulin therapy (PPT) injected three times a day to basal plus two times bolus insulin therapy (B2B) on glycemic control and quality of life were investigated in patients with type 2 diabetes mellitus. METHODS: The clinical course was prospectively observed during the first 16 weeks after switching to B2B (insulin glargine plus insulin glulisine before breakfast and dinner) in 27 subjects previously treated with PPT using 50/50 premixed insulin. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) was administered at the start and end of the study. RESULTS: The glycated hemoglobin (HbA(1c)) level (8.3%±1.8% to 8.2%±1.1%) and the DTSQ score did not change between the start and end of the study. An improvement in HbA(1c) level was found in nine (33%) subjects. The change in HbA(1c) showed a significant negative correlation with baseline HbA(1c), and was significantly better in patients with a baseline HbA(1c) >8.0% than in those with an HbA(1c) ≤8.0% (−0.9±2.0 versus 0.3±0.6, respectively, P=0.02). The change in DTSQ score representing treatment satisfaction was significantly greater in patients whose HbA(1c) level was improved than in those in whom it was not (2.7±3.6 versus −0.8±3.5, P=0.04). CONCLUSION: B2B was noninferior to PPT with regard to HbA(1c) levels in patients with type 2 diabetes mellitus. B2B should be considered particularly for subjects whose glycemic control is poor despite PPT. Dove Medical Press 2014-04-23 /pmc/articles/PMC4003145/ /pubmed/24790413 http://dx.doi.org/10.2147/DDDT.S62709 Text en © 2014 Ito et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Ito, Hiroyuki Abe, Mariko Antoku, Shinichi Omoto, Takashi Shinozaki, Masahiro Nishio, Shinya Mifune, Mizuo Togane, Michiko Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus |
title | Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus |
title_full | Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus |
title_fullStr | Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus |
title_full_unstemmed | Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus |
title_short | Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus |
title_sort | effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003145/ https://www.ncbi.nlm.nih.gov/pubmed/24790413 http://dx.doi.org/10.2147/DDDT.S62709 |
work_keys_str_mv | AT itohiroyuki effectsofswitchingfromprandialpremixedinsulintherapytobasalplustwotimesbolusinsulintherapyonglycemiccontrolandqualityoflifeinpatientswithtype2diabetesmellitus AT abemariko effectsofswitchingfromprandialpremixedinsulintherapytobasalplustwotimesbolusinsulintherapyonglycemiccontrolandqualityoflifeinpatientswithtype2diabetesmellitus AT antokushinichi effectsofswitchingfromprandialpremixedinsulintherapytobasalplustwotimesbolusinsulintherapyonglycemiccontrolandqualityoflifeinpatientswithtype2diabetesmellitus AT omototakashi effectsofswitchingfromprandialpremixedinsulintherapytobasalplustwotimesbolusinsulintherapyonglycemiccontrolandqualityoflifeinpatientswithtype2diabetesmellitus AT shinozakimasahiro effectsofswitchingfromprandialpremixedinsulintherapytobasalplustwotimesbolusinsulintherapyonglycemiccontrolandqualityoflifeinpatientswithtype2diabetesmellitus AT nishioshinya effectsofswitchingfromprandialpremixedinsulintherapytobasalplustwotimesbolusinsulintherapyonglycemiccontrolandqualityoflifeinpatientswithtype2diabetesmellitus AT mifunemizuo effectsofswitchingfromprandialpremixedinsulintherapytobasalplustwotimesbolusinsulintherapyonglycemiccontrolandqualityoflifeinpatientswithtype2diabetesmellitus AT toganemichiko effectsofswitchingfromprandialpremixedinsulintherapytobasalplustwotimesbolusinsulintherapyonglycemiccontrolandqualityoflifeinpatientswithtype2diabetesmellitus |